5 Ways to Prioritize Your Heart Health During Heart Month

American Heart Month aims to raise awareness about the risks and signs of heart disease, and to encourage more Americans to make healthy decisions. Nearly half of adults in the U.S. have cardiovascular disease and 1 in every 4 deaths are attributed to heart disease. Shockingly, our recent consumer survey found that 71 percent of Americans were unaware that heart disease is the leading cause of death.

In addition, Health and Human Services recently found that the number of younger individuals (35-64) with heart disease is rising, although the death rates from heart disease are slowing. These findings illustrate that despite efforts, Americans are still struggling to understand the risks of heart disease. We hope to provide better information to increase that understanding.

Knowing the facts and changing what’s in your control are key first steps.

When it comes to heart disease, there are several factors to consider such as lifestyle, family history and age. The CDC reports that 47 percent of Americans have at least one of the three biggest risk factors, including high cholesterol levels, high blood pressure and smoking. The bad news is that your family history and age are not something you can change. The good news is that you can take control of your lifestyle to not only ward off the risk of heart disease but to help improve your overall health.

To help you on that journey, we’ve outlined five ways you can prioritize your health and combat the risk of heart disease.

  1. If you smoke, quit now! This is the first and hardest step but smokingfree.gov finds that with a proper plan, identifying triggers and distraction techniques, quitting is possible.
  2. Get the blood pumping with a workout. Regular exercise has many benefits beyond just physical health. Exercise reduces stress, releases endorphins, improves sleep and much more. The American Heart Association recommends at least 150 minutes of exercise per week, which can range from walking to cycling. Customize your workouts and do something you love.
  3. Eat a well-balanced diet. Similar to exercise, maintaining a healthy diet can benefit your overall health. Aim to eat more vegetables (frozen or fresh) and lean protein (grilled chicken, salmon, turkey breast, etc.) with each meal. Don’t forget, snacks count, so think twice before grabbing the potato chips over an apple or celery sticks. The CDC outlines useful guidelines on diet here.
  4. Take your health into your own hands. Establish a relationship with your physician as a key first step to better manage your health. Discuss your family history of heart disease, your blood pressure and cholesterol numbers, plus any questions you have about new products or data you have researched.
  5. Follow the doctor’s orders. Once you’ve established a strong relationship with your doctor, listen and follow the plan they have outlined for you—whether that is to lose weight, eat a balanced diet or take your prescription. If you have concerns or side effects, it is important to discuss these with your doctor as well.

To learn more about heart disease, click here. If you’re interested in learning more about HeartFlow and the HeartFlow Analysis, click here.

© 2023 HeartFlow, Inc. | HeartFlow and the HeartFlow logo, CT-Flow and the CT-Flow logo, are registered trademarks of HeartFlow, Inc. Additionally, RoadMap is claimed as a trademark of HeartFlow, Inc.

The HeartFlow Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease. The information provided by the HeartFlow Analysis is intended to be used in conjunction with the patient’s clinical history, symptoms and other diagnostic tests, as well as the clinician’s professional judgment. Patient symptoms must be documented in the patient’s medical record. While no diagnostic test is perfect, the HeartFlow Analysis has demonstrated higher diagnostic performance compared to other non-invasive cardiac tests1. If you are a patient and suspect this test may be right for you, please speak with your doctor.

1. Nørgaard, et al. J Am Coll Cardiol. 2014; Driessen, et al. J Am Coll Cardiol. 2018.

Contact Us

*Required fields

Request the HeartFlow Analysis Near You

If you would like to request to have the HeartFlow Analysis available at a location near you, please submit your information below with details of the institution. We will share this information with the institution, but it will not guarantee HeartFlow will become available.

*Required fields

残念ながら、GDPR 規制により、この Web フォームを通じて求人への応募やキャリアに関する問い合わせを受け付けることはできません。弊社を通じてお申込みください 採用ページ. ご関心をお寄せいただきありがとうございます!


HeartFlow FFRCT 分析は、有資格の臨床医による臨床的に安定した症状のある冠状動脈疾患患者への使用を目的とした個別化された心臓検査です。 HeartFlow Analysis によって提供される情報は、資格のある臨床医が患者の病歴、症状、その他の診断検査、および臨床医の専門的判断と組み合わせて使用​​することを目的としています。


さらに質問がある場合は、このメッセージを閉じてフォームに記入するか、サポート チームにお電話ください。: 877.478.3569.

The HeartFlow FFRCT Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease by qualified clinicians. The information provided by the HeartFlow Analysis is intended to be used by qualified clinicians in conjunction with the patient’s history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement.

For additional indication information about the HeartFlow Analysis, please visit www.heartflow.com/indications.

If you have additional questions, close out of this message to complete our form or call our support team: 877.478.3569.

Please apply for research grants through our online submission form.

Unfortunately, we cannot take job applications or career inquiries through this web form due to GDPR regulations. Please apply through our Careers Page. Thank you for your interest!

Campbell Rogers, M.D., F.A.C.C.

Executive Vice President and Chief Medical Officer

Campbell brings a wealth of experience to HeartFlow, where he serves as the Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA.

He received his A.B. from Harvard College and his M.D. from Harvard Medical School.